Peptides 101: What They Are and How They Work
A plain-language primer on peptide therapy — what peptides actually do in the body, and why dosing precision matters.
Read articleNAD+ shows up in nearly every conversation about cellular energy and aging — and increasingly in injectable form at recovery clinics. Here's what the coenzyme actually does, and what's actually been proven in humans.
NAD+ (nicotinamide adenine dinucleotide) is one of the more scientifically legitimate names in the recovery and longevity space — it's not a fringe molecule, it's a coenzyme every one of your cells genuinely depends on. That's exactly why it's worth separating the real biology from what's actually been demonstrated when it's given as an injection or IV.
NAD+ is required for the core chemical reactions that turn food into usable cellular energy, and it's also the fuel that two other important enzyme families run on: sirtuins, which help regulate genes, mitochondrial function, and how cells respond to stress, and PARPs, which repair damaged DNA. As you age, NAD+-consuming enzymes become more active while your body's ability to make new NAD+ slows down, and total NAD+ levels measurably decline in animal studies and some human tissue research. That decline is the real, well-supported starting point for the theory that restoring NAD+ levels could support energy, cellular repair, and healthy aging.
Here's the distinction that tends to get lost in marketing: the theory above is well established, but actual human trial evidence for injected or IV NAD+ specifically is sparse. Most of the more rigorous human research uses oral NAD+ precursors — nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) — not injected NAD+ itself. A 2025 randomized, placebo-controlled pilot study of an oral NR-based supplement did find it reliably raised blood NAD+ levels, and found a modest quality-of-life benefit in male participants specifically on two subscales, with no significant effect in female participants or on a broader validated health survey.
For injected or IV NAD+, the picture is thinner still. One of the only published human studies specific to IV NAD+ is a small 2026 retrospective pilot comparing IV NAD+ to IV NR in a real-world clinic setting — six patients on NAD+, eight on NR, no placebo group. It was designed to check tolerability and standard safety bloodwork, not to measure whether it actually improved energy, cognition, or any other outcome, and it explicitly can't answer that question. No large, controlled human trial has demonstrated that NAD+ injections improve energy, mental clarity, exercise performance, or slow any measurable aging process. That gap between the underlying biology (well-supported) and the injectable-specific clinical benefit (largely unproven in humans) is the most important thing to understand before trying it.
NAD+ has no FDA-approved application as an injectable drug for any use. The agency has taken this seriously enough to issue warning letters to companies marketing unapproved NAD+ injectable products as recently as early 2026, citing the lack of any approved application and inadequate directions for safe use of an injectable product. Separately, NMN — an oral NAD+ precursor sold as a supplement, not NAD+ itself — went through its own multi-year regulatory dispute over whether it could legally be sold as a dietary supplement at all; that dispute was resolved in NMN's favor in late 2025, but it's a distinct question from whether injectable NAD+ is an approved drug, which it is not.
IV NAD+ is typically given as a slow infusion, often run over an hour or more, specifically because infusing it too quickly tends to cause uncomfortable side effects — flushing, nausea, and a tight or pressured feeling in the chest during the infusion are commonly reported, and the pilot study above documented these directly. Injectable (subcutaneous or intramuscular) NAD+ is sometimes offered as a faster, lower-dose option between IV sessions. Dosing protocols vary widely between providers because no standardized regimen has been established in the research literature — that's worth knowing going in, since it means you're evaluating a specific provider's judgment more than a proven, standardized treatment.
NAD+'s underlying role in cellular energy and repair is real, well-documented biology — that part isn't hype. What's not yet established is that raising it through an injection or IV translates into a noticeable, measurable benefit for a healthy adult. If you're considering it, that's worth discussing directly with a licensed clinician who can be honest with you about where the evidence currently stands, rather than treating it as a settled, proven therapy.
This article is for educational purposes and does not constitute medical advice. Motion protocols are prescribed only after an independent licensed clinician evaluates your individual health history.